Brief: Galera Therapeutics reports Q2 results
09/08/2022 12:51
Aug 9 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
RECENT
CORPORATE UPDATES
* Q2 LOSS PER SHARE $0.54
Source text for Eikon: ID:nGNXMRQf3
Further company coverage: GRTX.O
Recent news on Obsidian Therapeutics
See all newsBrief: Obsidian Therapeutics - Files Prospectus Relates To Resale Of Up To 29,164,045 Shares Of Common Stock By Selling Stockholders- SEC Filing
NASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
NASDAQ RESUMED AT 11:05 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:00 AM